Neoadjuvant antibody-drug conjugates for early-stage breast cancer: A systematic review and meta-analysis.
- DOI
- 10.1016/j.critrevonc.2026.105602
- Published
- 2026 Sep 22
- Container
- Critical reviews in oncology/hematology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.critrevonc.2026.105602,
title = {Neoadjuvant antibody-drug conjugates for early-stage breast cancer: A systematic review and meta-analysis.},
author = {E Silva GB and Simões AR and Nohmi RL and da Silva RH and de Oliveira Bretas G and Tarantino P and de Oliveira Andrade M},
year = {2026},
journal = {Critical reviews in oncology/hematology},
doi = {10.1016/j.critrevonc.2026.105602},
url = {https://doi.org/10.1016/j.critrevonc.2026.105602}
}RIS
TY - JOUR TI - Neoadjuvant antibody-drug conjugates for early-stage breast cancer: A systematic review and meta-analysis. AU - E Silva GB AU - Simões AR AU - Nohmi RL AU - da Silva RH AU - de Oliveira Bretas G AU - Tarantino P AU - de Oliveira Andrade M PY - 2026 JO - Critical reviews in oncology/hematology DO - 10.1016/j.critrevonc.2026.105602 UR - https://doi.org/10.1016/j.critrevonc.2026.105602 ER -
APA
GB, E. S., AR, S., RL, N., RH, D. S., G, D. O. B., P, T., & M, D. O. A. (2026). Neoadjuvant antibody-drug conjugates for early-stage breast cancer: A systematic review and meta-analysis.. Critical reviews in oncology/hematology. https://doi.org/10.1016/j.critrevonc.2026.105602
Source records
- pubmed · retrieved 2026-09-25T15:19:34.333Z